Trends in psychostimulant and antidepressant use by children in 2 Canadian provinces

Canadian Journal of Psychiatry

Volumn 53, Issue 3, 2008, Pages 152-159

  Mitchell, Brendon ^a   Carleton, Bruce ^b,c   Smith, Anne ^c   Prosser, Robert ^b   Brownell, Marni ^d   Kozyrskyj, Anita ^d  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Adolescent; Amphetamines; Antidepressive agents; British Columbia; Child; Drug prescriptions; Drug use; Epidemiology; Manitoba; Methylphenidate; Psychotropic drugs

Indexed keywords

ANTIDEPRESSANT AGENT; DEXAMPHETAMINE; METHYLPHENIDATE; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; ARTICLE; CANADA; DRUG UTILIZATION; FEMALE; HEALTH CARE POLICY; HUMAN; MALE; PRESCHOOL CHILD; PRESCRIPTION; PREVALENCE; SCHOOL CHILD;

EID: 41549122531     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674370805300305     Document Type: Article

References (35)

1. Zito JM, Safer DJ, dosReis S, et al. Psychotropic practice patterns for youth: a 10-year perspective. Arch Pediatr Adolesc Med. 2003;157(1):17-25.
2. Guevara J, Lozano P, Wickizer T, et al. Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder. Pediatrics. 2002;109(5):733-739.
3. Olfson M, Gameroff MJ, Marcus SC, et al. National trends in the treatment of attention deficit hyperactivity disorder. Am J Psychiatry. 2003;160(6):1071-1077.
4. Zuvekas SH, Vitiello B, Norquist GS. Recent trends in stimulant medication use among US children. Am J Psychiatry. 2006;163(4):579-585.
5. Vitiello B, Zuvekas SH, Norquist GS. National estimates of antidepressant medication use among US children, 1997-2002. J Am Acad Child Adolesc Psychiatry. 2006;45(3):271-279.
6. Gifford-Jones W. Drugging children a sad and cruel sign of our times [Internet]. Toronto (ON): Canada Free Press; 2006 [cited 2008 Jan 8]. Available from: http://www.canadafreepress.com/medical/psychiatry062106.htm.
7. Kluger J. Medicating young minds. TIME Magazine. 2003 Nov 3.
8. Tanner L. Study shows surge in psychiatric drugs for young people. Chicago (IL): Associated Press, 2003 Jan 13.
9. Efron D, Hiscock H, Sewell JR, et al. Prescribing of psychotropic medications for children by Australian pediatricians and child psychiatrists. Pediatrics. 2003;111(2):372-375.
10. Vitiello B. Psychopharmacology for young children: clinical needs and research opportunities. Pediatrics. 2001;108:983-989.
11. Ray WA, Schaffner W, Federspiel CF. Differences between female and male children in the receipt of prescribed psychotropic and controlled-analgesic drugs. A five-year epidemiologic study. Med Care. 1986;24(9):801-813.
12. Zito JM, Safer DJ, Riddle MA, et al. Prevalence variations in psychotropic treatment of children. J Child Adolesc Psychopharmacol. 1998;8(2):99-105.
13. van der Waals FW, Mohrs J, Foets M. Sex differences among recipients of benzodiazepines in Dutch general practice. BMJ. 1993;307(6900):363-366.
14. Zito JM, Safer DJ, dosReis S, et al. Methylphenidate patterns among Medicaid youths. Psychopharmacol Bull. 1997;33(1):143-147.
15. Zito JM, Safer DJ, dosReis S, et al. Trends in the prescribing of psychotropic medications to preschoolers. JAMA. 2000;283(8):1025-1030.
16. Rappley MD, Eneli IU, Mullan PB, et al. Patterns of psychotropic medication use in very young children with attention-deficit hyperactivity disorder. J Dev Behav Pediatr. 2002;23(1):23-30.
17. DeBar LL, Lynch F, Powell J, et al. Use of psychotropic agents in preschool children: associated symptoms, diagnoses, and health care services in a health maintenance organization. Arch Pediatr Adolesc Med. 2003;157(2):150-157.
18. Thomas CP, Conrad P, Casler R, et al. Trends in the use of psychotropic medications among adolescents, 1994 to 2001. Psychiatr Serv. 2006;57(1):63-69.
19. Zito JM, Safer DJ, dosReis S, et al. Rising prevalence of antidepressants among US youths. Pediatrics. 2002;109(5):721-727.
20. Murray ML, de Vries CS, Wong IC. A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database. Arch Dis Child. 2004;89(12):1098-1102.
21. Schirm E, Tobi H, Zito JM, et al. Psychotropic medication in children: a study from the Netherlands. Pediatrics. 2001;108(2):E25.
22. Miller AR, Lalonde CE, McGrail KM, et al. Prescription of methylphenidate to children and youth, 1990-1996. CMAJ. 2001;165(11):1489-1494.
23. Ivis FJ, Adlaf EM. Prevalence of methylphenidate use among adolescents in Ontario. Can J Public Health. 1999;90(5):309-312.
24. Brownell MD, Yogendran MS. Attention-deficit hyperactivity disorder in Manitoba children: medical diagnosis and psychostimulant treatment rates. Can J Psychiatry. 2001;46(3):264-272.
25. Kozyrskyj AL. Prescription medications in Manitoba children: are there regional differences? Can J Public Health. 2002;93(Suppl 2):S63-S69.
26. Rappley MD, Gardiner JC, Jetton JR, et al. The use of methylphenidate in Michigan. Arch Pediatr Adolesc Med. 1995;149(6):675-679.
27. Jensen PS, Kettle L, Roper MT, et al. Are stimulants overprescribed? Treatment of ADHD in four US communities. J Am Acad Child Adolesc Psychiatry. 1999;38(7):797-804.
28. Cox ER, Motheral BR, Henderson RR, et al. Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old: results from a commercially insured US sample. Pediatrics. 2003;111(2):237-243.
29. Kozyrskyj AL, Mustard CA. Validation of an electronic, population-based prescription database. Ann Pharmacother. 1998;32(11):1152-1157.
30. Taylor BTB. A review of Ritalin prescribing by the College of Physicians and Surgeons of British Columbia [Internet]. Vancouver (BC): College of Physicians and Surgeons of British Columbia; 2000 [cited 2006 Dec 10]. Available from: https://www.cpsbc.ca/cps/general_info/communications/press_releases/2004/ 04/19_0404261228-250.
31. BC PharmaCare. 2004. PharmaCare Trends 2003 [Internet]. Victoria (BC): BC Ministry of Health Services; 2004 [cited 2006 Dec 18]. Available from: http://www.health.gov.bc.ca/pharme/pharmacare_trends_2003.pdf.
32. Zito JM, Safer DJ, dosReis S, et al. Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 1999;153(12):1257-1263.
33. Health Canada. Important Safety Information Regarding Paxil in Pediatric Patients [Internet]. Ottawa (ON): Health Canada Public Advisory, Health Canada, 2003 [cited 2006 Dec 14]. Available from: http://www.hc-sc.gc.ca/dhp-mps/medeff/ advisories-avis/public/2003/paxil_pa-ap_e.html.
34. US Food and Drug Administration. FDA Statement on Recommendations of the Psychopharmacologic Drugs and Pediatric Advisory Committees [Internet]. Rockville (MD): US FDA Public Advisory, US Department of Health and Human Services, 2004 [cited 2006 Dec 14]. Available from: http://www.fda.gov/bbs/ topics/news/2004/NEW01116.html.
35. Health Canada. Health Canada advises Canadians under the age of 18 to consult physicians if they are being treated with newer anti-depressants [Internet]. Ottawa (ON): Health Canada Public Advisory, Health Canada, 2004 [cited 2006 Dec 14]. Available from: http://www.hc-sc.gc.ca/ahc-asc/media/ advisories-avis/2004/2004_02_e.html.